Turn real-world clinical data into real-world outcomes.
Cetaira combines a proven agentic Human+AI platform with longitudinal clinical data — helping healthcare organizations turn real-world data into market-ready deliverables without building complex AI infrastructure.
Real operating proof, not pilot promises
What we stand for
Six anchors for every conversation
These are not taglines. They are the operating principles that shape every customer engagement, every commercial motion, and every piece of work we deliver.
Data Sitting in a Warehouse Is Not a Strategy
Most organizations are not limited by the amount of data they have; they are limited by whether that data is organized, governed, and ready to answer real business and regulatory questions. Cetaira designs structured data assets by starting with the questions first, then builds the data layer around it to deliver timely answers that meet client needs.
Indication-Specific Evidence, Built to Your Brand's Commercial Timeline
Medical affairs and HEOR teams are expected to deliver publication-ready, payer-facing evidence on timelines that match launch, access negotiations, and formulary cycles. Cetaira builds evidence programs with clear milestones so market access teams have exactly what they need, when they need it.
Our AI Operates Inside Clinical and Commercial Workflows, Not Alongside Them
Putting AI into healthcare systems is easy; the real challenge is making sure the right person acts on its recommendations at the right moment in a patient’s journey, and proving that action changed the outcome. Cetaira’s platform plugs into clinical and commercial workflows to flag care gaps, trigger adherence support, and send live outcome data back into the evidence layer.
Health System Partners Retain Full Governance. That Is Non-Negotiable.
Most health systems and IDNs that work with industry partners gradually lose control of their data. Cetaira’s model keeps all data within your environment, with without data export. Your institution remains in control with IRB-compliant research frameworks, and tiered access for every sponsored study while creating new funding streams without giving up data ownership or control.
CROs and Pharma Services Firms Can Embed Our Capabilities as Their Own
Pressure on CROs and pharma service providers is increasing as clients demand AI-native capabilities that most organizations cannot build quickly enough. Cetaira offers a white-label agentic AI solution your team can deploy under your own brand, enabling you to deliver AI- native capabilities and giving you clear differentiation from competitors.
Every Program Must Create Value Across All Stakeholders
Too many industry partnerships ask health systems, clinicians, and patients to bear the burden while only sponsors see the upside. Cetaira designs every engagement as a “win-win” so that all key stakeholders receive value – from commercial lift and actionable insight to measurable quality and utilization improvements, and better patient care.
The Platform
Three engines. One integrated platform.
Data, Discovery, and Delivery work as one — so every program produces evidence and action simultaneously.
Data Engine
The clinical evidence foundation that Biopharma, CROs, and payers can trust.
Cetaira transforms fragmented longitudinal clinical records into governed, analysis-ready data assets — structured around the specific therapeutic area, patient population, and endpoint framework a sponsor needs. We handle EHR extraction, claims linkage, de-identification, phenotyping, and cohort construction.
Deliverables
- Indication-specific cohorts available for analysis within hours of data access agreement
- Payer-ready endpoints pre-mapped to formulary and HTA submission requirements
- Federated architecture that keeps health system partners in full governance control
- Longitudinal patient-level records with 3+ years of follow-up in core therapeutic areas
Discovery Engine
Evidence generation programs that deliver prospective “living” publications, not retrospective analytics.
The Discovery Engine is where clinical data becomes decision-grade evidence, defensible in a regulatory or payer submission. As providers deliver more data, evidence grows richer, with every patient interaction feeding the next generation of clinical evidence.
Deliverables
- Living Clinical Articles that update automatically as real-world patient data evolves — turning static literature into dynamic, evidence-based guidance
- RWE studies, retrospective analyses, and observational cohort studies tied to brand milestones
- HEOR modeling aligned to payer access timelines, brand launch cycles, and formulary requirements that accelerate market access
Delivery Engine
Agentic patient journeys that close care gaps and generate outcomes you can measure.
The Delivery Engine is where evidence becomes action. Cetaira deploys agentic AI workflows that identify patients at risk of disease progression, care gap, or therapy discontinuation, and route the right intervention to the right care team or patient-facing touchpoint before the adverse event occurs. Every intervention is tracked and every outcome feeds back to the data layer.
Deliverables
- White-labeled patient journeys — your logo, your colors, your domain; clients see your brand
- Real-time assessment of therapy support interventions at key patient journey touchpoints
- MLR-relevant program performance reporting for payer and provider clients
- Quality measure performance dashboards updated in real time
Who we serve
Four buyer segments. One commercial motion.
Each segment has distinct problems, internal stakeholders, and commercial entry points. We meet each on its own terms.
Primary segment
Biopharma and Device Manufacturers — Brand Management, Medical Affairs, HEOR & Market Access
Your brand needs evidence that drives adherence and persistence, moves payers, convinces formulary committees, and holds up under scrutiny — not in three years, but in the next two or three quarters. Cetaira builds indication-specific, RWE-based HEOR models, patient journey programs, and publication-ready manuscripts that address your brand's exact commercial questions. We have operated across oncology, rare disease, cardiometabolic, and immunology — in both pre-launch evidence building and post-launch outcomes demonstration.
When your C-suite, medical affairs, or HEOR lead says they need results now, we are the team that helps deliver it.
Data partner
Health Systems & IDNs
Your EHR contains years of longitudinal clinical data the pharmaceutical and life sciences industry is willing to pay to access — but your legal, compliance, and research governance teams have legitimate reasons to keep commercial partners at arm's length. Cetaira's health system partnerships resolve that tension entirely: federated architecture means patient data never leaves your environment, you work within your IRB-compatible research framework, and every sponsored research question requires your explicit approval before analysis begins.
In exchange, you receive non-dilutive revenue from sponsored research partnerships, co-authorship on publications, and research infrastructure your teams can use independently.
Delivery showcase
Payers & Preventive Health
Your care programs are spending money. The question your actuarial team and your board keep asking is: on what, and did it work? Generic population health interventions produce generic results — and they rarely map cleanly to the HEDIS measures, quality scores, and MLR outcomes you are actually measured against. Cetaira builds member journey programs designed from the start around the quality metrics and cost outcomes your plan is accountable for.
Our agentic AI identifies members at risk of care gap, high-cost event, or therapy discontinuation — and deploys targeted, multi-touchpoint interventions with member-level outcome attribution. Programs are live in 60 days, not 18 months.
Capability partner
CROs & Pharma Services
Your sponsors are asking for AI-native RWE capabilities on every RFP. Your competitors are promising them. If your organization cannot show a differentiated, embedded approach to real-world evidence and agentic AI, you will lose bids you should be winning — and retain fewer clients. Cetaira operates as your embedded capability layer.
We provide white-label RWE study design and execution, agentic workflow infrastructure, and sponsor-facing deliverables that carry your brand identity. Your team stays in front of the sponsor relationship; we provide the differentiated capability that makes you stickier than your nearest competitor.
Real World Proof: Already Operating. Already Delivering Results
Redefining Real World Evidence Through Real World Impact
Every customer-facing conversation anchors in a specific outcome from work already in the field — not a slideware promise.
10-Hospital IDN | Governed Data Asset Build
5TB of de-identified longitudinal clinical data, spanning a decade of records, transformed into a query-ready sponsor-accessible asset — federated infrastructure, IRB-approved governance, and a first sponsored research agreement generating non-dilutive revenue within 90 days.
Global Pharma Client | Formulary Pressure
Disease-focused data factory delivered an analysis-ready cohort of 4,200 patients with three-year longitudinal follow-up, a payer-ready endpoint package, and peer-ready publications on multi-drug-resistant infections — used by the client's market access team in a formulary consideration meeting.
Specialty Physician Society | CMS Quality Measures
Transformed 6M ED charts across 1.3M encounters from unstructured to structured format, calculating 11 CMS clinical quality measures at scale — establishing a replicable pipeline now used for annual quality reporting and an ongoing sponsored research program.
Regional Health Plan | HEDIS Care Gap Closure
Piloted a care gap closure program against a single HEDIS Diabetes measure, improving performance from the 38th to the 61st percentile nationally within 90 days — and below budget.
Lighthouse Engagements
Full-scope deployment for organizations ready to show results this year.
A lighthouse engagement is a fully scoped deployment combining at least two of our three engines around a single brand or indication — with defined commercial milestones, a named executive sponsor on both sides, and a governance structure that keeps the engagement on track from kickoff through publication or program launch.
Start with a conversation, not just a demo
Tell us what you are trying to prove — we will tell you if we can help.
Every Cetaira engagement begins with a 30-minute diagnostic call between our team and your project champion — at the level where decisions get made. Tell us where the friction is: payer pressure, an evidence gap, a stalled launch, or unmonetized data. We will tell you honestly whether we are the right fit and, if we are, come back with a one-page hypothesis and a focused engagement we can stand up in eight to twelve weeks.
- Paid pilots, defined evidence milestones
- Referenceable deliverables by design
- Co-developed with your medical, HEOR, or brand team